Results 21 to 30 of about 4,517,311 (361)

Self-regulated hirudin delivery for anticoagulant therapy

open access: yesScience Advances, 2020
Polymeric nanogel with on-demand release of hirudin prevents and inhibits clot formation. Pathological coagulation, a disorder of blood clotting regulation, induces a number of cardiovascular diseases.
Xiao Xu   +7 more
semanticscholar   +1 more source

Anticoagulant therapy for splanchnic vein thrombosis

open access: yesJournal of Thrombosis and Haemostasis, 2020
1Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands 2Department of Medicine and Ageing Sciences, “G. D'Annunzio” University, Chieti-Pescara, Italy 3Department of Medical, Oral and Biotechnological Sciences, “G.
M. Di Nisio   +5 more
semanticscholar   +1 more source

Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

open access: yesBMC Family Practice, 2021
Background Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs).
Shera Chaterji   +7 more
doaj   +1 more source

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

open access: yesMutiara Medika, 2022
Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis.
Agus Fitriyanto Achmad   +5 more
doaj   +1 more source

Clinical audit of anticoagulant therapy with pregnancy

open access: yesAl-Azhar Assiut Medical Journal, 2020
Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy ...
Mahmoud I El-Rasheedy   +2 more
doaj   +1 more source

Future of Anticoagulant Therapy [PDF]

open access: yesCardiovascular Therapeutics, 2010
Prophylaxis and treatment of thromboembolic diseases is one of the main targets in medicine. Side effects and the necessity of dose adjustment limit the administration of coumarins and unfractionated heparin. Coumarins are therefore underused specially in the elderly population. Low-molecular-weight heparins, heparinoids, and direct thrombin inhibitors
Job Harenberg, Martin Wehling
openaire   +3 more sources

Does antithrombotic therapy improve survival with colorectal cancer?

open access: yesWorld Journal of Surgical Oncology, 2017
Background The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease stages 0–III.
Kodai Takahashi   +6 more
doaj   +1 more source

Mechanical thrombextraction in patient with acute ischemic stroke on background of oral anticoagulant therapy [PDF]

open access: yesКардіохірургія та інтервенційна кардіологія, 2021
Thrombolytic therapy, which is a priority treatment strategy in patients with acute ischemic stroke in the first 3-4.5 hours after start of the disease, has significant limitations in case of background anticoagulant therapy. Mechanic thrombextraction is
V.О. Yarosh   +5 more
doaj   +1 more source

A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran

open access: yesMedical Journal of Babylon, 2022
Variances in the patients’ outcomes have been a well-documented challenge in anticoagulant therapy. A clinical encounter with a thromboembolic or a hemorrhagic event, due to subtherapeutic or adverse effects of an anticoagulant, is often managed by ...
Ali Mohammed Abd Alridha   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy